Gold nanoparticles help lose fat more effectively than a common weight-loss drug, improving body fat levels and organ health ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person’s chance of developing diabetes, sleep apnea, certain cancers, heart disease ...

Ophthalmic complications were observed in patients using semaglutide and tirzepatide, but a causal link was not established. The study included nine patients, with conditions like nonarteritic ...

Eli Lilly achieved the largest market capitalisation growth of 32.4% to $733bn in 2024, driven by strong demand for its weight-loss drugs, Mounjaro (tirzepatide) and Zepbound (tirzepatide). However, ...

39,001 people played the daily Crossword recently. Can you solve it faster than others?39,001 people played the daily Crossword recently. Can you solve it faster than others?

The results raised MET-097i’s profile in an increasingly crowded field of GLP-1RAs where makers are trying to differentiate from the market leaders—Eli Lilly’s tirzepatide and Novo Nordisk’s ...

Mounjaro (tirzepatide) is a prescription drug used to help manage blood sugar levels in adults with type 2 diabetes. Mounjaro comes as an injection that’s given under your skin. This medication ...

the FDA has approved Novo Nordisk’s semaglutide for heart disease and Eli Lilly’s tirzepatide for sleep apnea. Now, as the companies run trials to flesh out the potential of the drugs to treat ...

The study included people taking different types drugs in this category—semaglutide (Wegovy and Ozempic), and tirzepatide (Mounjaro and Zepbound). While tirzepatide targets two hormones—GLP-1 ...

In December, the NHS spending watchdog recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for people with a body mass index (BMI) of more than 35 and at least one weight ...

Weight loss drugs like Ozempic and wegovy have become global sensation. In the recent years, companies like Novo Nordisk and Eli Lilly have GLP-1 agonists and dual GLP-1/GIP receptor agonists that ...